P M Loadman - JoVE Visualize

Showing results (21-30 of 40) with videos related to

Pageof 4

Sort By:

Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 2000

High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxideD J Swaine, P M Loadman, M C Bibby, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999

Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1P M Loadman, M C Bibby, J A Double, et al.

Anti-Cancer Drug Design|March 1, 1996

Pharmacokinetics and anti-tumour activity of B.4152, a reactive molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, and its uracil analogueP M Loadman, A M Matthew, J E McCormick, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001

A preclinical pharmacokinetic study of the bioreductive drug AQ4NP M Loadman, D J Swaine, M C Bibby, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1987

Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumoursM C Bibby, B J McDermott, J A Double, et al.

Royal Society Open Science|June 3, 2017

Drug delivery in a tumour cord model: a computational simulationM E Hubbard, M Jove, P M Loadman, et al.

Journal of Chemotherapy (Florence, Italy)|February 21, 2007

Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)A M Burger, P M Loadman, D E Thurston, et al.

Journal of Chromatography|March 22, 1985

Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimensB J McDermott, J A Double, M C Bibby, et al.

Cancer Research|December 5, 2000

Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug developmentR M Phillips, A M Burger, P M Loadman, et al.

Cancer Research|December 16, 1998

Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.

Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:

Pageof 4

Journal of Chromatography. B, Biomedical Sciences and Applications|July 20, 2000

High-performance liquid chromatographic analysis of AQ4N, an alkylaminoanthraquinone N-oxideD J Swaine, P M Loadman, M C Bibby, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999

Pharmacokinetics of PK1 and doxorubicin in experimental colon tumor models with differing responses to PK1P M Loadman, M C Bibby, J A Double, et al.

Anti-Cancer Drug Design|March 1, 1996

Pharmacokinetics and anti-tumour activity of B.4152, a reactive molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, and its uracil analogueP M Loadman, A M Matthew, J E McCormick, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001

A preclinical pharmacokinetic study of the bioreductive drug AQ4NP M Loadman, D J Swaine, M C Bibby, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1987

Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumoursM C Bibby, B J McDermott, J A Double, et al.

Royal Society Open Science|June 3, 2017

Drug delivery in a tumour cord model: a computational simulationM E Hubbard, M Jove, P M Loadman, et al.

Journal of Chemotherapy (Florence, Italy)|February 21, 2007

Preclinical pharmacology of the pyrrolobenzodiazepine (PBD) monomer DRH-417 (NSC 709119)A M Burger, P M Loadman, D E Thurston, et al.

Journal of Chromatography|March 22, 1985

Gas chromatographic analysis of triethylenethiophosphoramide and triethylenephosphoramide in biological specimensB J McDermott, J A Double, M C Bibby, et al.

Cancer Research|December 5, 2000

Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug developmentR M Phillips, A M Burger, P M Loadman, et al.

Cancer Research|December 16, 1998

Angiogenesis in the hollow fiber tumor model influences drug delivery to tumor cells: implications for anticancer drug screening programsR M Phillips, J Pearce, P M Loadman, et al.

Pageof 4